Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

686 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design and rationale for the Japanese Registry of Rivaroxaban Effectiveness & Safety for the Prevention of Recurrence in Patients with Deep Vein Thrombosis and Pulmonary Embolism (J'xactly) study.
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: fukuda i. BMJ Open. 2018 Jun 22;8(6):e020286. doi: 10.1136/bmjopen-2017-020286. BMJ Open. 2018. PMID: 29934383 Free PMC article.
Outcomes of Pulmonary Embolectomy for Acute Pulmonary Embolism.
Minakawa M, Fukuda I, Miyata H, Motomura N, Takamoto S, Taniguchi S, Daitoku K, Kondo N; Japan Cardiovascular Surgery Database Organization. Minakawa M, et al. Among authors: fukuda i. Circ J. 2018 Jul 25;82(8):2184-2190. doi: 10.1253/circj.CJ-18-0371. Epub 2018 Jun 27. Circ J. 2018. PMID: 29952349 Free article.
A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Kobayashi T, Niwa A, Matsuo H, Yokoi H, Koga M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: fukuda i. Circ J. 2020 Oct 23;84(11):1912-1921. doi: 10.1253/circj.CJ-20-0636. Epub 2020 Sep 26. Circ J. 2020. PMID: 32981924 Free article.
CORRIGENDUM: A Multicenter Prospective Observational Cohort Study to Investigate the Effectiveness and Safety of Rivaroxaban in Japanese Venous Thromboembolism Patients (The J'xactly Study).
Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Kobayashi T, Niwa A, Matsuo H, Yokoi H, Koga M, Yamazaki T, Hirayama A; J’xactly Investigators. Okumura Y, et al. Among authors: fukuda i. Circ J. 2021;85(3):330. doi: 10.1253/circj.CJ-66-0190. Circ J. 2021. PMID: 33627587 Free article. No abstract available.
Characteristics and clinical outcomes of Japanese patients with venous thromboembolism receiving under-dose rivaroxaban: subanalysis of J'xactly.
Fukamachi D, Okumura Y, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Yamashita T, Ikeda T, Mo M, Yamazaki T, Hirayama A; J’xactly Investigators. Fukamachi D, et al. Among authors: fukuda i. Curr Med Res Opin. 2022 Jul;38(7):1059-1068. doi: 10.1080/03007995.2022.2070379. Epub 2022 May 6. Curr Med Res Opin. 2022. PMID: 35502571 Free article.
Clinical Outcome After Discontinuation of Anticoagulation Therapy in Japanese Patients With Venous Thromboembolism　- Insights From the J'xactly Study.
Yamashita T, Fukuda I, Nakamura M, Yamada N, Takayama M, Maeda H, Ikeda T, Mo M, Yamazaki T, Okumura Y, Hirayama A; J’xactly Investigators. Yamashita T, et al. Among authors: fukuda i. Circ Rep. 2022 Jul 13;4(8):371-377. doi: 10.1253/circrep.CR-22-0011. eCollection 2022 Aug 10. Circ Rep. 2022. PMID: 36032386 Free PMC article.
686 results